Viewing Study NCT02890368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2025-12-30 @ 3:12 AM
Study NCT ID: NCT02890368
Status: TERMINATED
Last Update Posted: 2023-04-05
First Post: 2016-08-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
None Mycosis Fungoides View
None Melanoma View
None Merkel-cell Carcinoma View
None Squamous Cell Carcinoma View
None Breast Carcinoma View
None Human Papillomavirus-Related Malignant Neoplasm View
None Soft Tissue Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD47 View
None SIRPa View
None Immunotherapy View
None Checkpoint inhibitor View